Navigation Links
Lilly and Amylin Set Date and Time for Conference Call
Date:8/25/2008

Companies Will Discuss Recent FDA Advisory Regarding Byetta

INDIANAPOLIS, Aug. 25 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE: LLY) and Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) will host a conference call on Tuesday, August 26, 2008 at 5:00 p.m. EDT to discuss the recent FDA advisory on Byetta(R) (exenatide) injection. Participating in the call for Lilly will be Donald Therasse, M.D., vice president of global patient safety. Participating in the call for Amylin will be Daniel M. Bradbury, Amylin's president and chief executive officer, and Orville G. Kolterman, M.D., senior vice president of research and development.

Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at http://www.lilly.com or Amylin's website at http://www.amylin.com The webcast of the conference call will be available for replay through September 26, 2008. For those without access to the Internet, the live call may be accessed by phone by calling (866) 814-1915 (domestic) or (703) 639-1359 (international), passcode 1277182. A replay of the call will also be available by phone through September 26, 2008 beginning approximately one hour after the close of the call and can be accessed at (888) 266-2081 (domestic) or (703) 925-2533 (international), passcode 1277182.

About Eli Lilly and Company

Lilly, a leading innovation-d
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Lauren Marangell, M.D. to Join Lilly; Internationally Recognized Expert in Depression Joins as Distinguished Lilly Scholar
4. Genentech/Roches Lucentis and Eli Lillys Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets
5. Lillys CEO Calls for Reform of Nations Drug Safety System
6. Lilly Announces Updates to the Zyprexa and Symbyax U.S. Labels
7. Lilly Grant to VA Will Enhance Services for Returning Combat Veterans
8. Lilly Delivers Strong Third-Quarter Results
9. Lilly and MacroGenics Announce Licensing and Collaboration Agreement
10. Eli Lilly and Company Aids California Recovery Effort
11. Eli Lilly and Company Announces 2007 Lilly Reintegration Awards Recipients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... January 22, 2015 Deer Path of Huntley ... a Valentine’s Day Happy Hour from 3 p.m. to 4 p.m. ... Regency Parkway in Huntley, Illinois, serves adults with physical disabilities between ... will include Valentine's Day treats, games and sweetheart-themed karaoke. , For ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort located ... the number one best large hotel for families in the ... their annual Travelers’ Choice Awards. , TripAdvisor represents the ... home to millions of unbiased and honest traveler reviews. The ...
(Date:1/22/2015)... 2015 Angelweddingdress is a famous wedding dress ... customers to follow it on Facebook, Twitter, and Pinterest. The ... gift. Angelweddingdress draws a lottery every week. , Moreover, the ... 28, 2015. Click Angelweddingdress homepage for more information. ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
(Date:1/22/2015)... January 22, 2015 Joan Lunden, award-winning ... speaker at the upcoming 32nd Annual Miami Breast ... Physicians’ Education Resource®, LLC (PER®) , shares that “a ... gone undetected if she had not followed up her ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6
... PHILADELPHIA, Nov. 6 In a newly-published special supplement, ... policies to prevent and treat venous thromboembolism (VTE), a ... the world. Lippincott Williams & Wilkins (LWW) ... a disease that includes both the common medical condition ...
... Nov. 6 The American Academy of Nursing ... of Lippincott Williams & Wilkins (LWW) nursing publications ... Kluwer Health, a leading provider of information and ... medicine, nursing, allied health, and pharmacy. Academy Fellows ...
... DALLAS, Nov. 6 Lockton Benefit Group, the ... Companies, LLC, today announced employer health cost reduction ... U.S.-based healthcare company Concentra. , (Logo: ... a services provider to support Lockton,s clients with: ...
... play a role in boosting memories -- or forgetting them, ... Do you remember the first time you smelled a type ... that your brain might. , In the study, published ... researchers showed objects to adult study participants. They paired the ...
... to bronchiolitis, study finds , FRIDAY, Nov. 6 (HealthDay ... traffic as a risk factor for bronchiolitis, the respiratory ... the first year of life, a new study finds. ... appliances were more likely to show up in doctors, ...
... Researchers at Wake Forest University School of Medicine and the ... (PSA) levels in men may be caused by a hormone ... predictor of the need for a prostate biopsy. ... potential sign of prostate cancer, leading to the widespread use ...
Cached Medicine News:Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 2Health News:Journal of Cardiovascular Nursing Urges Policies and Prevention To Reduce Deaths from Venous Thromboembolism 3Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 2Health News:Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 3Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 2Health News:Lockton and Concentra Working Together to Lower Healthcare Costs for Employers 3Health News:New Smells 'Etched' in Brain: Study 2Health News:Wood Fires Can Harm the Youngest Lungs 2Health News:New finding suggests prostate biopsy is not always necessary 2Health News:New finding suggests prostate biopsy is not always necessary 3
(Date:1/22/2015)... is pleased to announce the appointment of Dr. ... Biochemistry. Scott joins the company after previous scientific leadership positions ... course of his nearly 20 year career in therapeutics ... recognized thought leader in the biosensor field and particularly ...
(Date:1/22/2015)... Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" ... on Omega-3 therapies for cardiovascular disease and overall health is ... accomplishments in 2014 and its outlook for 2015 from the ... Shareholders, We would like to take this opportunity ...
(Date:1/22/2015)... 2015  Profil Institute for Clinical Research, Inc., a clinical ... today a new textbook,  Translational Research Methods for Diabetes, ... leading global scientific publisher. The textbook is ... use in early phase clinical studies of new drugs ...
Breaking Medicine Technology:BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... Response Rate,in Two Clinical Trials , Clinical Data ... Exelixis Reports Comprehensive XL880 Phase I Data At ... II Clinical Trials,of XL999 at ASCO , Clinical ... Solid Tumors , Studies Investigating Vidaza in Alternate ...
... Presented at the , 2007 American Society of ... Older Patients with AML and in,Refractory , ALL ... of Aloxi(R),with , the 5-HT3 Receptor Reported-- , ... , with Multimodal Therapy, including Gliadel(R) Described-- , ...
Cached Medicine Technology:Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 2Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 3Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 4Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 5Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 6Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 7Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 8Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 9Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 10Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 11Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 12Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 13Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 14Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 15Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 16Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 17Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 18Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 19Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 20Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 21Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 22Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 23Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 24Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 25Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 26Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 27Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 28Clinical Data Reported on Vidaza in Hematologic Malignancies and,Advanced Solid Tumors 29MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8
... The EndoProbe handpieces, used for endophotocoagulation ... aspiration, 25 gauge, and illuminating models. ... the ophthalmologist with uncompromised laser treatment ... 3-meter, fiber-optic cables that are flexible ...
... The Rare Earth Intraocular Magnet is especially ... intraocular foreign bodies. The precise, sleek design ... commonly observed with electromagnetic devises. Due to ... minimizes the possibility of secondary foreign body ...
... On-line Electronic Help (OLEH), an ... to critical anesthesia-related information. OLEH brings ... need it most right on ... care of the patient and ...
... High-performance monitoring for flexible care settings., ... monitors combine portability and measurement flexibility ... needs of intermediate care environmentsat the ... strong heritage in patient monitoring, IntelliVue ...
Medicine Products: